CNE000001F21
CNE000001F21
ZHANGZHOU PIENTZEHUANG PHARMACE
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 72.29B EUR | 65.93B EUR | 91.16B EUR | 101.83B EUR |
Enterprise Value | 70.22B EUR | 64.85B EUR | 90.27B EUR | 101.63B EUR |
Valuation Multiples | ||||
Trailing P/E | 39.94x | 58.75x | 75.01x | 69.2x |
Forward P/E | 24.6x | -- | -- | -- |
Price to Sales | 8.82x | 10.75x | 13.94x | 14.68x |
Price to Book | 4.95x | 4.51x | 5.99x | 7x |
EV/Revenue | 8.57x | 10.58x | 13.81x | 14.65x |
EV/EBITDA | 38.6x | 45.94x | 59.73x | 55.56x |
Price to FCF (P/FCF) | 350.69x | 93.43x | 15,284.26x | -- |
EV/FCF | 340.63x | 91.9x | 15,135.24x | -- |
FCF Yield | 0.29% | 1.07% | 0.01% | -0.31% |